Marksans Pharma Ltd.

MARKSANS

₹184.25

3.17% (5.67)

Market Cap

₹8,080 Cr.

P/E

23.08

About

Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in research, manufacturing, and marketing of finished dosage pharmaceutical formulations. Their R&D strengths enco… Read more

Marksans Pharma is an Indian pharmaceutical company with a global presence, excelling in resea… Read more

Low

171

52W Range

High

359

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

3 Neutral

Neutral for this company

3 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales
Contingent Liabilities

Unable to calculate due to limited data

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
ROCE Strength

Roce of the company is consistently strong
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Margin Stability

Margins of the company are volatile

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Marksans Pharma Ltd. Business

What does Marksans Pharma do?

Who are the competitors of Marksans Pharma?

Marksans Pharma major competitors are Strides Pharma Scien, FDC, Procter&Gamble Healt, Sanofi India, Sequent Scientific, Zota Health Care, Guj. Themis Biosyn.
Market Cap of Marksans Pharma is ₹8,080 Crs.
While the median market cap of its peers are ₹7,759 Crs.

Is Marksans Pharma financially stable compared to its competitors?

Marksans Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Marksans Pharma is 9.15 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Oversold on RSI Basis

Stocks with RSI of less than 30.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec	Mar Jun Sep	Mar Jun Sep	Jun Dec	Jun		Mar	Sep Dec	Jun Sep
Investor Presentation	Feb May Aug	Feb Mar Jun Sep Dec	Mar Jun Sep Dec	Feb Mar May Jun Aug Sep Nov Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Jun Sep Dec
Conference Call	Mar	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep	Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Marksans Pharma Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Marksans Pharma Ltd.